Evidence map›Paper›PMID 39775375›Full record

ArticleAAPS PharmSciTech2025

In Silico and Experimental Evidence for the Stabilization of rhEPO by Glycine, Glutamic Acid and Lysine.

Yoshio Aldo Alarcón-López, Pablo Aguirre-Vidal, Hugo Víctor Vásquez-Valadez, Alejandro Manuel Hernández-Serda, Alfonso Luis Cárdenas-Granados, Carlos E Espinosa de la Garza, Néstor O Pérez, Enrique Angeles, Víctor Pérez Medina Martínez

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yoshio Aldo Alarcón-LópezLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México.
Pablo Aguirre-VidalLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México.
Hugo Víctor Vásquez-ValadezLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México.
Alejandro Manuel Hernández-SerdaLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México.
Alfonso Luis Cárdenas-GranadosLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México.
Carlos E Espinosa de la GarzaDirección de Operaciones, Probiomed S.A. de C.V. Cd. de México, C.P. 11520, México City, México.
Néstor O PérezDirección de Operaciones, Probiomed S.A. de C.V. Cd. de México, C.P. 11520, México City, México.
Enrique AngelesLaboratorio de Química Medicinal y Teórica FESC, Universidad Nacional Autónoma de México, Av. 1 de Mayo S/N Cuautitlán Izcalli, ZIP 54750, México City, Estado de México, México. angeles@unam.mx.
Víctor Pérez Medina MartínezUnidad de Investigación y Desarrollo, Probiomed S.A. de C.V, C. P. 52400, Tenancingo, Estado de México, México. victor.perez@probiomed.com.mx.ORCID http://orcid.org/0000-0001-6088-0765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The available literature indicates that amino acids can stabilize proteins. Our experimental data demonstrated that lysine and glutamic acid can stabilize recombinant human erythropoietin (rhEPO) at 40°C for at least 1 month, as measured by RP-UPLC. Studies with different excipient concentrations demonstrated optimal concentrations of these amino acids within 10-12 mM. The results suggest that a lower concentration of amino acids may not be sufficient to stabilize formulations, while a higher concentration of amino acids can lead lower stability. In silico studies highlighted the importance of the FA4G4S4 model in experimental glycosylation determination, particularly in glycoprotein analysis. We obtained insights into the interactions between the glycosylated ligands of rhEPO and amino acids, as well as their impact on protein behavior and stability. We observed different interactions between the amino acids glycine, glutamic acid, and lysine and the rhEPO protein using this model in docking experiments. They also made it easier to find specific interaction areas by analyzing ligand‒protein interaction fingerprints (PLIFs). This demonstrated how the ligands bind to the proteins or remain outside their vicinity. Furthermore, this study revealed specific places where ligands and rhEPO residues can interact, which helps us learn more about how they stabilize rhEPO.

Indexed as

Computer SimulationErythropoietinGlutamic AcidGlycineLysineRecombinant ProteinsChemistry, PharmaceuticalDrug StabilityExcipientsGlycosylationHumansLigandsMolecular Docking SimulationProtein StabilityErythropoietinExcipientsGlutamic AcidGlycineLigandsLysineRecombinant Proteinsglutamic acidlysineRhEPO stabilization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.